InvestSMART

Monash IVF Group Limited (ASX:MVF)

ALERT: Price-sensitive ASX Announcement for MVF
Current share price for MVF : $0.675 0.005 (0.75%)+
Announcement
Release
12 Jun 2026 8:24AM
Price at Release
$0.670
Full Release
download
Summary
Monash IVF Group Limited has issued a trading update indicating that its expected FY26 Underlying NPAT will be between $17 million to $18 million. This revision is largely due to a decline in the Australian Assisted Reproductive Technology (ART) market activities, with a notable 4.7% decrease in stimulated cycle volumes based on Medicare data. Despite the challenging market conditions, Monash IVF has managed to increase its national market share by 1% to 20.1%. The company's international operations have shown growth, with an expectation of significantly higher volumes in the second half of FY26 compared to the prior period. Efforts to enhance operational efficiency are in progress, although significant benefits are expected in FY27. The next update will be provided with the FY26 full-year results on 24 August 2026.
Key Points
  • FY26 Underlying NPAT expected to be $17-18 million.
  • Australian ART market activity decreased, impacting results.
  • Monash IVF increased national market share to 20.1%.
  • International operations expected to show growth in H2 FY26.
  • Operational improvements anticipated to benefit FY27.
  • Further results update on 24 August 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.